Breaking News

Tweet TWEET

Trinity Medical Center Adds Masimo Patient SafetyNet™ as a High Vigilance Safeguard for Post-Surgical Patients

  Trinity Medical Center Adds Masimo Patient SafetyNet™ as a High Vigilance
                     Safeguard for Post-Surgical Patients

Leading Alabama Hospital Leverages Masimo SET® Pulse Oximetry for Oxygenation
Monitoring and Masimo rainbow® Acoustic Monitoring for Ventilation Monitoring

PR Newswire

BIRMINGHAM, Ala. and IRVINE, Calif., Nov. 12, 2012

BIRMINGHAM, Ala.and IRVINE, Calif., Nov. 12, 2012 /PRNewswire/ --Masimo
(NASDAQ: MASI) and Trinity Medical Center announced today the successful
installation of Masimo Patient SafetyNet™, clinically shown to reduce rapid
response activations and intensive care unit (ICU) transfers, while offering
significant potential cost savings.^1

Trinity joins a growing list of outstanding hospitals using Patient SafetyNet
to track the underlying physiological conditions of post-surgical patients and
detect changes or abnormalities that signal declining health status in
real-time. When a patient's condition deteriorates, the system automatically
sends wireless alerts directly to clinicians – prompting a potentially
lifesaving response to the patient's bedside.

Trinity also is using rainbow^® Acoustic Monitoring, which noninvasively and
continuously measures a patient's respiration rate using an innovative
adhesive sensor with an integrated acoustic transducer that is easily and
comfortably applied to the patient's neck. Acoustic Respiration Rate (RRa™) is
a breakthrough measurement that facilitates earlier detection of respiratory
compromise and patient distress – especially important for post-surgical
patients receiving patient-controlled analgesia for pain management, as the
sedation can induce respiratory depression and place patients at considerable
risk of serious injury or death.^2-4

"Incorporating new technologies plays a key role in nurturing our culture of
patient safety," said Keith Granger, President and CEO of Trinity Medical
Center. "Our clinicians are finding this equipment to be a valuable tool as we
work to continue to improve patient care."

Patient SafetyNet can help hospitals comply with The Joint Commission's
Sentinel Event Alert released earlier this year that focused on the
recommendation to continuously monitor post-surgical patients for possible
adverse opioid effects.^5 Fortunately, improved care does not need to come at
a higher cost. Clinicians at Dartmouth-Hitchcock Medical Center in New
Hampshire reported that using the Masimo Patient SafetyNet system on just one
floor reduced ICU transfers and created an annual opportunity-cost savings of
$1.48 million.^1

Joe Kiani, Chairman and CEO of Masimo, stated: "We are happy that our
breakthrough technologies help Trinity Medical Center's dedicated staff
provide their patients with the best care possible. Each day we work to
improve patient safety and reduce healthcare costs. With Masimo technologies
on the general floor, clinicians can be confident their patients are being
safely monitored even when they aren't at the bedside."

Trinity Medical Center has been named one of the nation's Top Performers on
Key Quality Measures by The Joint Commission, the leading accreditor of health
care organizations in the United States. The hospital was recognized by The
Joint Commission for exemplary performance in using evidence-based clinical
processes that are shown to improve care for certain conditions, including
heart attack, heart failure, pneumonia, surgical care, children's asthma,
stroke and venous thrombo embolism.

1 Taenzer A, Blike G, McGrath S, Pyke J, Herrick M, Renaud C, Morgan J.
"Postoperative Monitoring – The Dartmouth Experience." Anesthesia Patient
Safety Foundation Newsletter Spring-Summer 2012. Available online
2 Joint Commission on Accreditation of Healthcare Organizations. Sentinel
event alert: patient controlled analgesia by proxy; JCAHO. 2004.
3 Institute for Safe Medication Practices. Safety issues with
patient-controlled analgesia: Part I – How errors occur; ISMP. 2003.
4 Bird M. Acute pain management: a new area of liability for
anesthesiologists; ASA Newsletter. 2007; 71:8.
5 The Joint Commission. Sentinel event alert: Safe use of opioids in
hospitals; 2012

About Trinity Medical Center
Trinity Medical Center is a tertiary care hospital serving residents of
Birmingham, Alabama, and surrounding communities. The hospital offers programs
and services in all medical and surgical areas. This includes oncology,
cardiology, robotic surgery, orthopedics, neurology, women's health, mental
health, digestive diseases, geriatrics, physical medicine and rehab, sports
medicine, cardiac and pulmonary rehab, and emergency care. Trinity Medical
Center has been named one of the nation's Top Performers on Key Quality
Measures by The Joint Commission, the leading accreditor of health care
organizations in the United States. The hospital was recognized by The Joint
Commission for exemplary performance in using evidence-based clinical
processes that are shown to improve care for certain conditions, including
heart attack, heart failure, pneumonia and surgical care. For more information
about Trinity Medical Center visit www.trinitymedicalonline.com.

About Masimo
Masimo (NASDAQ: MASI) is the global leader in innovative noninvasive
monitoring technologies that significantly improve patient care—helping solve
"unsolvable" problems. In 1995, the company debuted Measure-Through Motion and
Low Perfusion pulse oximetry, known as Masimo SET^®, which virtually
eliminated false alarms and increased pulse oximetry's ability to detect
life-threatening events. More than 100 independent and objective studies have
shown that Masimo SET^® outperforms other pulse oximetry technologies, even
under the most challenging clinical conditions, including patient motion and
low peripheral perfusion. In 2005, Masimo introduced rainbow SET^® Pulse
CO-Oximetry technology, allowing noninvasive and continuous monitoring of
blood constituents that previously required invasive procedures, including
total hemoglobin (SpHb^®), oxygen content (SpOC^TM), carboxyhemoglobin
(SpCO^®), methemoglobin (SpMet^®), and Pleth Variability Index (PVI^®), in
addition to SpO[2], pulse rate, and perfusion index (PI). In 2008, Masimo
introduced Patient SafetyNet™, a remote monitoring and wireless clinician
notification system designed to help hospitals avoid preventable deaths and
injuries associated with failure to rescue events. In 2009, Masimo introduced
rainbow^® Acoustic Monitoring^TM, the first-ever noninvasive and continuous
monitoring of acoustic respiration rate (RRa™).Masimo's rainbow^® SET^®
technology platform offers a breakthrough in patient safety by helping
clinicians detect life-threatening conditions and helping guide treatment
options. In 2010, Masimo acquired SEDLine^®, a pioneer in the development of
innovative brain function monitoring technology and devices. In 2012, Masimo
acquired assets of Spire Semiconductor, LLC, maker of advanced light emitting
diode (LED) and other advanced component-level technologies; and acquired
PHASEIN AB, a developer and manufacturer of ultra-compact mainstream and
sidestream capnography, multigas analyzers, and handheld capnometry solutions.
Masimo SET^® and Masimo rainbow^® SET^® technologies also can be found in over
100 multiparameter patient monitors from over 50 medical device manufacturers
around the world. Founded in 1989, Masimo has the mission of "Improving
Patient Outcome and Reducing Cost of Care … by Taking Noninvasive Monitoring
to New Sites and Applications^®." Additional information about Masimo and its
products may be found at www.masimo.com.

Forward-Looking Statements
This press release includes forward-looking statements as defined in Section
27A of the Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934, in connection with the Private Securities Litigation Reform Act
of 1995. These forward-looking statements are based on current expectations
about future events affecting us and are subject to risks and uncertainties,
all of which are difficult to predict and many of which are beyond our control
and could cause our actual results to differ materially and adversely from
those expressed in our forward-looking statements as a result of various risk
factors, including, but not limited to: risks related to our assumptions
regarding the repeatability of clinical results; risks related to our belief
that Masimo's unique noninvasive measurement technologies, including: acoustic
respiration rate (RRa™) and Patient SafetyNet contribute to positive clinical
outcomes and patient safety; risks related to our belief that Masimo
noninvasive medical breakthroughs provide cost-effective solutions with
comparable accuracy and unique advantages, including: immediate and continuous
results that enable earlier treatment without causing invasive trauma in all
patients and in every clinical situation; as well as other factors discussed
in the "Risk Factors" section of our most recent reports filed with the
Securities and Exchange Commission ("SEC"), which may be obtained for free at
the SEC's website at www.sec.gov. Although we believe that the expectations
reflected in our forward-looking statements are reasonable, we do not know
whether our expectations will prove correct. All forward-looking statements
included in this press release are expressly qualified in their entirety by
the foregoing cautionary statements. You are cautioned not to place undue
reliance on these forward-looking statements, which speak only as of today's
date. We do not undertake any obligation to update, amend or clarify these
statements or the "Risk Factors" contained in our most recent reports filed
with the SEC, whether as a result of new information, future events or
otherwise, except as may be required under the applicable securities laws.

Media Contacts:
Leisha Harris                          Mike Drummond
Trinity Medical Center                 Masimo Corporation
(205) 599-4926                         (949) 297-7434
Leisha.harris@trinitymedicalonline.com mdrummond@masimo.com

Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and
Reducing Cost of Care... by Taking Noninvasive Monitoring to New Sites and
Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI, rainbow Acoustic
Monitoring, RRa, Radical-7, Rad-87, Rad-57,Rad-8, Rad-5,Pulse CO-Oximetry,
Pulse CO-Oximeter, Adaptive Threshold Alarm, and SEDLine are trademarks or
registered trademarks of Masimo Corporation. The use of the trademarks Patient
SafetyNet and PSN are under license from University HealthSystem Consortium.

SOURCE Masimo

Website: http://www.masimo.com